youtube_live
Fitimet për Q3 2026 • publikuar • Fitimet për aksion janë tejkaluar +11,45% • Të ardhurat janë tejkaluar +3,01%
Shiko rezultatetchevron_right
AMGN34:BVMF
Amgen Inc. BDR
93,78Â BRL
0,00%
(0,00) 1D
4 nën, 5:39:47 m.d., GMT-3 · BRL
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMGN34...
Hap
91,80Â BRL
I lartë
93,78Â BRL
I ulët
91,80Â BRL
Kapitalizimi i tregut
258,68Â mld
Vëllimi mesatar
423,00
Vëllimi
30,00
Maksimumi 52-javor
93,78Â BRL
Minimumi 52-javor
47,76Â BRL
Aksionet në qarkullim
540,63Â mln
Numri i punonjësve
32 mijë
Hap
91,80Â BRL
I lartë
93,78Â BRL
I ulët
91,80Â BRL
Kapitalizimi i tregut
258,68Â mld
Vëllimi mesatar
423,00
Vëllimi
30,00
Maksimumi 52-javor
93,78Â BRL
Minimumi 52-javor
47,76Â BRL
Aksionet në qarkullim
540,63Â mln
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
GuruFocus
·
5 orë më parë
Amgen Inc (AMGN) Shares Surge 3.7% -- What GF Score of 85 Tells Investors
MarketWatch
·
6 orë më parë
Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains
marketscreener.com
·
10 orë më parë
Amgen's Diversified Base Business Warrants Higher Multiple, UBS Says
Yahoo Finance
·
11 orë më parë
Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc. BDR
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
Sektori-
Industry-
Uebsajtiamgen.com